InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Hoelscher Paul W., Chief Financial Officer. Director active across 1 company, notably Horizon Therapeutics Public Ltd Co. Aggregated, 8 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €7.7m. Activity tracked since 14 May 2021. The latest transaction was disclosed on 20 April 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Hoelscher Paul W.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
50,000 shares@ US$22.146.1% of flowOrdinary SharesSEC:0001209191-22-025455:0
30,275 shares@ US$15.962.6% of flowOrdinary SharesSEC:0001209191-22-023845:0
66,626 shares0Ordinary SharesSEC:0001209191-22-021151:0
5,558 shares0Ordinary SharesSEC:0001209191-22-004633:0
66,822 sharesOrdinary SharesSEC:0001209191-22-002291:0
6,163 shares0Ordinary SharesSEC:0001209191-21-071650:0
8,708 shares0Ordinary SharesSEC:0001209191-21-048788:0
102,925 shares@ US$90.005884.0% of flowOrdinary SharesSEC:0001209191-21-032882:0
8 of 8 declarations
About Hoelscher Paul W.
Hoelscher Paul W. serves as CFO at Horizon Therapeutics Public Ltd Co. He is responsible for the financial management of the company, including budgeting and performance analysis. His expertise is essential for ensuring the financial health and growth of the organization.
